Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

A Novel SDHB IVS2-2A>C Mutation Is Responsible for Hereditary Pheochromocytoma/Paraganglioma Syndrome.

Yamanaka M, Shiga K, Fujiwara S, Mizuguchi Y, Yasuda S, Ishizawa K, Saiki Y, Higashi K, Ogawa T, Kimura N, Horii A.

Tohoku J Exp Med. 2018 Jun;245(2):99-105. doi: 10.1620/tjem.245.99.

2.

Tracheal paraganglioma presenting as stridor in a pediatric patient, case report and literature review.

Dimachkieh AL, Dobbie A, Olson DR, Lovell MA, Prager JD.

Int J Pediatr Otorhinolaryngol. 2018 Apr;107:145-149. doi: 10.1016/j.ijporl.2018.02.010. Epub 2018 Feb 7. Review.

PMID:
29501297
3.

Cardiac paraganglioma with a novel germline mutation of succinate dehydrogenase gene D.

Otani N, Sugano K, Inami S, Amano H, Arikawa T, Saito S, Imai K, Ushiama M, Yoshida T, Kimura N, Toyoda S, Inoue T.

Jpn J Clin Oncol. 2017 Dec 1;47(12):1193-1197. doi: 10.1093/jjco/hyx132.

PMID:
28977582
4.

Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.

Yim SY, Moncayo VM, Pasquel FJ, Halkar RK.

Clin Nucl Med. 2017 Dec;42(12):964-965. doi: 10.1097/RLU.0000000000001841.

PMID:
28902732
5.

Mandibular Lytic Lesion in Familial Paraganglioma Syndrome Type I: A Clinical Conundrum.

Sinha P, Yuen SN, Chernock RD, Haughey BH.

Ann Otol Rhinol Laryngol. 2017 Aug;126(8):615-618. doi: 10.1177/0003489417717502. Epub 2017 Jul 1.

PMID:
28670912
6.

Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD.

Clin Cancer Res. 2017 Jun 15;23(12):e68-e75. doi: 10.1158/1078-0432.CCR-17-0547. Review.

7.

The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.

Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Kerstens MN, Dreijerink KMA, van Dooren MF, van der Horst-Schrivers ANA, Hes FJ, Leemans CR, Corssmit EPM, Hensen EF.

Clin Genet. 2018 Jan;93(1):60-66. doi: 10.1111/cge.13055. Epub 2017 Sep 6.

PMID:
28503760
8.

Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.

Hoekstra AS, Hensen EF, Jordanova ES, Korpershoek E, van der Horst-Schrivers AN, Cornelisse C, Corssmit EP, Hes FJ, Jansen JC, Kunst HP, Timmers HJ, Bateman A, Eccles D, Bovée JV, Devilee P, Bayley JP.

Oncotarget. 2017 Feb 28;8(9):14525-14536. doi: 10.18632/oncotarget.14649.

9.

Genetic predisposition to endocrine tumors: Diagnosis, surveillance and challenges in care.

Petr EJ, Else T.

Semin Oncol. 2016 Oct;43(5):582-590. doi: 10.1053/j.seminoncol.2016.08.007. Epub 2016 Sep 21. Review.

PMID:
27899191
10.

Four generations of SDHB-related disease: complexities in management.

Srirangalingam U, LeCain M, Tufton N, Akker SA, Drake WM, Metcalfe K.

Fam Cancer. 2017 Apr;16(2):279-282. doi: 10.1007/s10689-016-9946-9.

11.

Familial paraganglioma syndrome: a rare cause of carotid artery occlusion.

Rosafio F, Dell'Acqua ML, Madeo B, Kara E, Vandelli L, Vallone S, Bigliardi G, Picchetto L, Nichelli P, Zini A.

J Neurol. 2016 Dec;263(12):2544-2546. Epub 2016 Oct 20. No abstract available.

PMID:
27766470
12.

Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas.

Srirangalingam U, Banerjee A, Patki P, Peters J, George E, Chew SL, Kumar VKA, Korbonits M, Waterhouse M, Druce MR, Sahdev A, Drake WM, Akker SA.

Clin Genitourin Cancer. 2017 Feb;15(1):e131-e136. doi: 10.1016/j.clgc.2016.06.006. Epub 2016 Jun 23. No abstract available.

PMID:
27542510
13.

Simple and rapid characterization of novel large germline deletions in SDHB, SDHC and SDHD-related paraganglioma.

Hoekstra AS, van den Ende B, Julià XP, van Breemen L, Scheurwater K, Tops CM, Malinoc A, Devilee P, Neumann HP, Bayley JP.

Clin Genet. 2017 Apr;91(4):536-544. doi: 10.1111/cge.12843. Epub 2016 Dec 6.

PMID:
27485256
14.

Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.

Hoekstra AS, Addie RD, Ras C, Seifar RM, Ruivenkamp CA, Briaire-de Bruijn IH, Hes FJ, Jansen JC, Corssmit EP, Corver WE, Morreau H, Bovée JV, Bayley JP, Devilee P.

Hum Mol Genet. 2016 Sep 1;25(17):3715-3728. doi: 10.1093/hmg/ddw218. Epub 2016 Jul 8.

PMID:
27402879
15.

A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma.

Sagong B, Seo YJ, Lee HJ, Kim MJ, Kim UK, Moon IS.

Fam Cancer. 2016 Oct;15(4):601-6. doi: 10.1007/s10689-016-9874-8.

PMID:
26833045
16.

A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.

Knie B, Plotkin M, Zschieschang P, Prasad V, Moskopp D.

Nuklearmedizin. 2016;55(1):34-40. doi: 10.3413/Nukmed-0755-15-07. Epub 2016 Jan 7.

PMID:
26740102
17.
18.
19.

15 YEARS OF PARAGANGLIOMA: Pheochromocytoma, paraganglioma and genetic syndromes: a historical perspective.

Else T.

Endocr Relat Cancer. 2015 Aug;22(4):T147-59. doi: 10.1530/ERC-15-0221. Review.

PMID:
26273101
20.

Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions.

Anupindi SA, Bedoya MA, Lindell RB, Rambhatla SJ, Zelley K, Nichols KE, Chauvin NA.

AJR Am J Roentgenol. 2015 Aug;205(2):400-8. doi: 10.2214/AJR.14.13663.

PMID:
26204294

Supplemental Content

Loading ...
Support Center